Nadav Kidron, CEO and director of Oramed Pharmaceuticals, discusses his company’s medical breakthrough in adapting insulin so that it can be taken as a pill instead of a shot. Can this technology be used for other kinds of medication? What does this mean for modern medicine?
Advertisement
SHARE
Previous articlePresident Rivlin Tells Arab Media Ramadan Based on ‘Compassion’
Next articleIt’s Q Time!
Doug Goldstein, CFP®
http://www.profile-financial.com
Douglas Goldstein, CFP®, is the director of Profile Investment Services, Ltd, a financial planning and investment services firm specializing in working with Americans living in Israel who have investment accounts in America. He is a licensed financial professional both in the U.S. and Israel. Securities offered through Portfolio Resources Group, Inc., Member FINRA, SIPC, MSRB, FSI. Accounts held at Pershing LLC., Member NYSE/SIPC, a subsidiary of The Bank of New York Mellon Corporation. Neither Profile nor PRG gives tax or legal advice. Before immigrating to Israel, it is advisable to consult with a tax attorney who is knowledgeable about Israeli law. Contact at [email protected]